Investors followed upbeat drugs data from pharmaceutical giant AstraZeneca (AZN) pushing the stock towards the top of the FTSE 100 leader board on Tuesday (15 February 2022).Astra reported positive results from Phase III trials of cancer drug Lynparza which showed a reduced risk of disease progression in castration resistant prostate cancer by a third.The shares rallied more than 3% to £86.69.Res

Troubled mother and baby products retailer Mothercare (MTC) falls 4.1% to 179.13p on reports it has been forced to renegotiate bank loan terms a mere seven months after refinancing. The embattled high street brand, currently guided by interim chief executive officer Mark Newton-Jones, rocked the market with a severe profit warning in January. Responding to the media speculation, Mothercare says it

Last week's disconcerting inflation data from the eurozone (31 Jan) explain precisely why Mr Short Term believes a portfolio heavily weighted towards bonds will not be a one-way route to capital losses, even after a 30-year bull market in fixed interest.Ultimately he believes global growth will disappoint and central banks be forced to further loosen monetary policy to keep benchmark sovereign bor